Japan's ONO Pharmaceutical to buy Deciphera for $2.4 billion
29/04/2024 12:06
April 29 (Reuters) - Deciphera Pharmaceuticals DCPH.O said on Monday Japan's ONO Pharmaceutical Co 4528.T will acquire the company for $2.4 billion in cash. (Reporting by Leroy Leo in Bengaluru; Editing by Shinjini Ganguli) ((Leroy.Dsouza@thomsonreuters.com ; https://twitter.com/LeroyLeo7;))
Recent news on ONO PHARMACEUTICAL
See all newsBrief: Biohaven Enters Strategic Licensing Agreement With Ono Pharma
Ono Pharma Announces An Exclusive License Agreement With Biohaven To Develop And Commercialize Igg Degraders In Japan, South Korea, Taiwan, And Asean
Bristol Myers sues Amgen over proposed Opdivo biosimilar (updated)
Bristol Myers sues Amgen over proposed Opdivo biosimilar
Brief: UK's MHRA Says Vimseltinib Approved For Use In Adults To Treat Tenosynovial Giant Cell Tumours